Related Experiment Video

Updated: Jan 9, 2026

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
10:10

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

4.5K

Optimized MASH Treatment Eligibility Cutoffs for MRE-measured Liver Stiffness and Proton Density Fat Fraction

Nana Owusu1, Kyle Kalutkiewicz2, Jiahui Li1

  • 1Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States.

Clinical and Molecular Hepatology
|December 8, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Biomarker optimizationFibrosis stageResmetiromSemaglutideTreatment eligibility

More Related Videos

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.8K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

417

Related Experiment Videos

Last Updated: Jan 9, 2026

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
10:10

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

4.5K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.8K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

417

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

506
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
506

Articles linked to this work by shared authors, journal, and citation graph.

Simplified definition and imaging-based stratification of at-risk MASH using magnetic resonance elastography.

Hepatology communications·2026

Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds.

Hepatology communications·2026

Diagnostic Deserts: National Gaps in Screening and Care Infrastructure for Metabolic Dysfunction-Associated Steatotic Liver Disease.

The American journal of gastroenterology·2026

Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia.

Clinics in liver disease·2026

Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities.

Annals of hepatology·2026

Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastroenterology·2026

Toward AI Virtual Cells for Hepatology: Representation, Generation, Dynamics, and Intervention in Single-Cell Models.

Clinical and molecular hepatology·2026

Hepatocyte Plasticity in Liver Health and Disease: Zonation, Regeneration, Lineage Conversion, and Hepatic Malignancy.

Clinical and molecular hepatology·2026

RNAi-mediated HBV antigen shutdown enhances the antiviral immune effects of PEGIFNα via T and B cell crosstalk remodeling.

Clinical and molecular hepatology·2026

Risk Assessment in MASLD and MetALD: Current Approaches and Future Directions.

Clinical and molecular hepatology·2026

Alcohol-Aware Risk Stratification and Subtype-Specific Care Pathways Across MASLD, MetALD, and ALD.

Clinical and molecular hepatology·2026

Long-Term Liver Outcomes in Wilson's Disease: Predictors of Survival and Hepatocellular Carcinoma.

Clinical and molecular hepatology·2026

Reduction in T-Cell Mitochondrial Respiratory Capacity After Reaching a Weight Loss Plateau.

Diabetes·2026

Changes in seminal plasma metabolites and the vital role of tyrosol in men with asthenozoospermia.

Asian journal of andrology·2026

Artemisinin and its derivatives for metabolic syndrome: From multi‑target mechanisms to translational opportunities (Review).

Molecular medicine reports·2026

Mitochondria‑associated endoplasmic reticulum membranes in degenerative musculoskeletal disorders: Mechanistic evidence and therapeutic perspectives (Review).

Molecular medicine reports·2026

Severe Hypokalemia With Rhabdomyolysis-A Case Report.

Clinical case reports·2026

Beyond a Single Snapshot: Inflammatory Markers in Acute-on-chronic Liver Failure.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us